The Obesity Wars of 2026 continue: Novo's Miss, Lilly's Supremacy, and the Quality of Weight Loss Pivot PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Obesity pharmacotherapy in older adults: a narrative review of evidence International Journal of Obesity #zepbound vs #cagrisema ( #Wegovy cagrilintide combo) Head to Head in new phase 3 trial!